Skip to main content

Advertisement

SpringerLink
Log in

Psychosomatic aspects of Cushing’s syndrome

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

Abstract

There has been growing interest in the psychosocial aspects of Cushing’s syndrome, such as the role of life stress as a pathogenetic factor, the association with affective disorders, and the presence of residual symptoms after treatment. Interestingly, a temporal relationship between stressful life events and disease onset is relevant only to pituitary-dependent Cushing’s disease, and not to the pituitary-independent forms. A number of psychiatric and psychological disturbances may be associated with the active hypercortisolemic state, regardless of its etiology. Within the high frequency of mood disorders (about 60%), major depression is the most common complication. Other psychopathological aspects include mania, anxiety disorders, psychological symptoms (demoralization, irritable mood, somatization) and cognitive impairment. Cognitive symptoms are associated with brain abnormalities (mainly loss of brain volume). Quality of life may be seriously compromised during both active and post-treatment phases. Long-standing hypercortisolism may imply a degree of irreversibility of the pathological process. Recovery, thus, may be delayed and be influenced by highly individualized affective responses. Outcomes of Cushing’s syndrome treatment are not fully satisfactory. Within its great complexity, a conceptual shift from a merely biomedical care to a psychosomatic consideration of the person and his/her quality of life appears to be necessary to improve effectiveness. It is time to translate the research evidence that has accumulated into clinical practice initiatives. To patients who show persistence or even worsening of psychological distress upon adequate endocrine treatment psychiatric/psychological interventions should be readily available. Applying interdisciplinary expertise and addressing the needs for rehabilitation would markedly improve final outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Santos A, Resmini E, Martinez MA, Marti C, Ybarra J, Webb SM. Quality of life in patients with pituitary tumors. Curr Opin Endocrinol Diabetes Obes. 2009;16:299–303.

    PubMed  Google Scholar 

  2. Sonino N, Tomba E, Fava GA. Psychosocial approach to endocrine disease. In: Porcelli P, Sonino N, editors. Psychosocial Factors Affecting Medical Conditions: a new classification for DSM-V. Adv Psychosom Med, vol. 28. Basel: Karger; 2007. p. 21–33.

    Google Scholar 

  3. Sonino N, Fava GA. Psychological aspects of endocrine disease. Clin Endocrinol. 1998;49:1–7.

    Article  CAS  Google Scholar 

  4. van der Klaaum AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, et al. Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol. 2008;69:775–84.

    Article  Google Scholar 

  5. Sonino N, Navarrini C, Ottolini F, Paoletta A, Fallo F, Boscaro M, et al. Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom. 2004;73:78–83.

    Article  PubMed  Google Scholar 

  6. Sobrinho LG. Psychopathology in endocrine disorders: why so persistent after the cure? Psychother Psychosom. 2004;73:65–7.

    Article  PubMed  Google Scholar 

  7. Fava GA, Sonino N. Psychosomatic assessment. Psychother Psychosom. 2009;78:333–41.

    Article  PubMed  Google Scholar 

  8. Cushing H. Psychic disturbances associated with disorders of the ductless glands. Am J Insanity. 1913;69:965–90.

    Google Scholar 

  9. Sonino N. From the lesson of Harvey Cushing to current knowledge: psychosocial aspects of endocrine disease. Psychother Psychosom. 1997;66:113–6.

    Article  CAS  PubMed  Google Scholar 

  10. Bech P. Fifty years with the Hamilton scales for anxiety and depression. Psychother Psychosom. 2009;78:202–11.

    Article  CAS  PubMed  Google Scholar 

  11. Fava GA, Sonino N. Psychosomatic medicine. Int J Clin Pract (in press)

  12. Wright JG, Feinstein AR. A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales. J Clin Epidemiol. 1992;45:1201–18.

    Article  CAS  PubMed  Google Scholar 

  13. Shonkoff JP, Boice WT, McEwen BS. Neuroscience, molecular biology, and the childhood roots of health disparities. JAMA. 2009;301:2252–9.

    Article  CAS  PubMed  Google Scholar 

  14. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Int Med. 1993;153:2093–101.

    Article  CAS  Google Scholar 

  15. Hellhammer DH, Wurst S, Kudielka BM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009;34:163–71.

    Article  CAS  PubMed  Google Scholar 

  16. Chida Y, Steptoe A. Positive psychological well-being and mortality. Psychosom Med. 2008;70:741–56.

    Article  PubMed  Google Scholar 

  17. Fava GA, Tomba E. Increasing psychological well-being and resilience by psychotherapeutic methods. J Personality 2009; Oct 6 [Epub ahead of print]

  18. Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, et al. No health without mental health. Lancet. 2007;370:859–77.

    Article  PubMed  Google Scholar 

  19. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216–26.

    Article  PubMed  Google Scholar 

  20. Sievers C, Ising M, Pfister H, Dimopoulou C, Schneider HJ, Roemmler J, et al. Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls. Eur J Endocrinol. 2009;160:367–73.

    Article  CAS  PubMed  Google Scholar 

  21. Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJG, Goodwin RD, Kubzansky L, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30:208–25.

    Article  PubMed  Google Scholar 

  22. Porcelli P, Sonino N. Psychological factors affecting medical conditions. A new classification for DSM-V. Basel: Karger; 2007.

    Google Scholar 

  23. Sirri L, Grandi S, Fava GA. The illness attitude scales. A clinimetric index for assessing hypocondriacal fears and beliefs. Psychother Psychosom. 2008;77:337–50.

    Article  PubMed  Google Scholar 

  24. Webb SM, Badia X, Barahona MJ, Colao A, Strasburger C, Tabarin A, et al. Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire. Eur J Endocrinol. 2008;158:623–30.

    Article  CAS  PubMed  Google Scholar 

  25. Pecori Giraldi F. Recent challenges in the diagnosis of Cushing’s syndrome. Horm Res. 2009;71(Suppl. 1):123–7.

    Article  CAS  PubMed  Google Scholar 

  26. Mullan KR, Atkinson B. Endocrine clinical update: Where are we in the therapeutic management of pituitary-dependent hypercortisolism? Clin Endocrinol. 2008;68:327–37.

    CAS  Google Scholar 

  27. Boscaro M, Barzon L, Sonino N. The diagnosis of Cushing’s syndrome: atypical presentations and laboratory shortcomings. Arch Intern Med. 2000;160:3045–63.

    Article  CAS  PubMed  Google Scholar 

  28. Barahona MJ, Sucunza N, Resmini E, Fernandez-Real JM, Ricart W, Moreno-Navarrete JM, et al. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing’s syndrome. J Clin Endocrinol Metab 2009;94:3365–71.

    Google Scholar 

  29. Pivonello R, De Martino MC, De Leo M, Tauchmanovà L, Faggiano A, Lombardi G, et al. Cushing’s syndrome: aftermath of the cure. Arq Bras Endocrinol Metab. 2007;51:1381–91.

    Article  Google Scholar 

  30. Sonino N, Fava GA. Psychosomatic aspects of Cushing’s disease. Psychother Psychosom. 1998;67:140–6.

    Article  CAS  PubMed  Google Scholar 

  31. Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M. Risk factors and long-term outcome in pituitary-dependent Cushing’s disease. J Clin Endocrinol Metab. 1996;81:2647–52.

    Article  CAS  PubMed  Google Scholar 

  32. Sonino N, Boscaro M, Fallo F, Fava GA. A clinical index for rating severity in Cushing’s syndrome. Psychother Psychosom. 2000;69:216–20.

    Article  CAS  PubMed  Google Scholar 

  33. Boscaro M, Barzon L, Fallo F, Sonino N. Cushing’s syndrome. Lancet. 2001;357:783–91.

    Article  CAS  PubMed  Google Scholar 

  34. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet. 2006;367:1605–17.

    Article  CAS  PubMed  Google Scholar 

  35. Sonino N, Fava GA, Boscaro M. A role for life events in the pathogenesis of Cushing’s disease. Clin Endocrinol. 1993;38:261–4.

    Article  CAS  Google Scholar 

  36. Paykel ES. The interview for recent life events. Psychol Med. 1997;27:301–10.

    Article  CAS  PubMed  Google Scholar 

  37. Sonino N, Fava GA. Psychiatric disorders associated with Cushing’s syndrome. CNS Drugs. 2001;15:361–73.

    Article  CAS  PubMed  Google Scholar 

  38. Haskett RF. Diagnostic categorization of psychiatric disturbance in Cushing’s syndrome. Am J Psychiatry. 1985;142:911–16.

    CAS  PubMed  Google Scholar 

  39. Hudson JI, Hudson MS, Griffing GT, Melby JC, Pope HG. Phenomenology and family history of affective disorder in Cushing’s disease. Am J Psychiatry. 1987;144:951–3.

    CAS  PubMed  Google Scholar 

  40. Loosen PT, Chambliss B, de Bold CR, Shelton R, Orth DN. Psychiatric phenomenology in Cushing’s disease. Pharmacopsychiatry. 1992;25:192–8.

    Article  CAS  Google Scholar 

  41. Dorn LD, Burgess ES, Dubbert B, Simpson SE, Friedman T, Kling M, et al. Psychopathology in patients with endogenous Cushing’s syndrome: atypical or melancholic features. Clin Endocrinol. 1995;43:433–42.

    Article  CAS  Google Scholar 

  42. Kelly WF. Psychiatric aspects of Cushing’s syndrome. Q J Med. 1996;89:543–51.

    CAS  Google Scholar 

  43. Sonino N, Fava GA. CNS drugs in Cushing’s disease: patophysiological and therapeutic implications for mood disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:1011–8.

    Article  PubMed  Google Scholar 

  44. Sonino N, Ruini C, Navarrini C, Ottolini F, Sirri L, Paoletta A, et al. Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol. 2007;67:719–26.

    Article  Google Scholar 

  45. Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP. The longitudinal course of psychopathology in Cushing’s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab. 1997;82:912–9.

    Article  CAS  PubMed  Google Scholar 

  46. Mahen FS, Mazzone L, Merke DP, Keil MF, Stratakis CA, Pine DS, et al. Altered amygdala and hippocampus function in adolescents with hypercortisolemia: a functional magnetic resonance imaging study of Cushing’s syndrome. Dev Psychopathol. 2008;20:1177–89.

    Article  Google Scholar 

  47. Bourdeau I, Bard C, Forget H, Boulanger Y, Cohen H, Lacroix A. Cognitive function and cerebral assessment in patients who have Cushing’s syndrome. Endocrinol Metab Clin N Am. 2005;34:357–69.

    Article  CAS  Google Scholar 

  48. Merke DP, Giedd JN, Keil MF, Mehlinger SL, Wiggs EA, Holzer S, et al. Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing’s syndrome. J Clin Endocrinol Metab. 2005;90:2531–6.

    Article  CAS  PubMed  Google Scholar 

  49. Forget H, Lacroix A, Cohen H. Persistent cognitive impairment following surgical treatment of Cushing’s syndrome. Psychoneuroendocrinology. 2002;27:367–83.

    Article  PubMed  Google Scholar 

  50. Tooze A, Gittoes NJ, Jones CA, Toogood AA. Neurocognitive consequences of surgery and radiotherapy for tumours of the pituitary. Clin Endocrinol. 2009;70:503–11.

    Article  Google Scholar 

  51. Dorn LD, Cerrone P. Cognitive function in patients with Cushing’s syndrome. A longitudinal perspective. Clin Nurs Res. 2000;9:420–40.

    Article  CAS  PubMed  Google Scholar 

  52. Gotch PM. Cushing’s syndrome from the patient perspective. Endocrinol Metab Clin N Am. 1994;23:607–17.

    CAS  Google Scholar 

  53. Armstrong A, Fachnie JD. The phenomenology of Cushing’s syndrome: one patient account. Henry Ford Hosp Med J. 1991;39:8–9.

    CAS  PubMed  Google Scholar 

  54. Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA. Personality characteristics and quality of life in patients treated for Cushing’s syndrome. Clin Endocrinol. 2006;64:314–8.

    Article  Google Scholar 

  55. Keil MF, Merke DP, Gandhi R, Wiggs EA, Obunse K, Stratakis CA. Quality of life in children and adolescents 1-year after cure of Cushing’s syndrome: a prospective study. Clin Endocrinol. 2009;71:326–33.

    Article  Google Scholar 

  56. Sippel RS, Elaraj DM, Kebebew E, Lindsay S, Tyrrel JB, Duh QY. Waiting for change: symptom resolution after adrenalectomy for Cushing’s syndrome. Surgery. 2008;144:1054–61.

    Article  PubMed  Google Scholar 

  57. Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK. Long term impaired quality of life in Cushing’s syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab. 2006;91:447–53.

    Article  CAS  PubMed  Google Scholar 

  58. van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer Smit JWA, Roelfsema F, et al. Quality of life in patients after long-term biochemical cure of Cushing’s disease. J Clin Endocrinol Metab. 2005;90:3279–86.

    Article  PubMed  Google Scholar 

  59. Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, et al. Long-term negative impact on quality of life in patients with successfully treated Cushing’s disease. Clin Endocrinol. 2004;61:458–65.

    Article  Google Scholar 

  60. Johnson MD, Woodburn CJ, Vance ML. Quality of life in patients with pituitary adenoma. Pituitary. 2003;6:81–7.

    Article  PubMed  Google Scholar 

  61. Pikkarainen L, Sane T, Reunanen A. The survival and well-being of patients treated for Cushing’s syndrome. J Int Med. 1999;245:463–8.

    Article  CAS  Google Scholar 

  62. Sonino N, Fava GA, Belluardo P, Girelli ME, Boscaro M. Course of depression in Cushing’s syndrome: response to treatment and comparison with Graves’ disease. Horm Res. 1993;39:202–6.

    Article  CAS  PubMed  Google Scholar 

  63. Fitzsimons CP, van Hooijdonk LW, Morrow JA, Peeters BW, Hamilton N, Craighead M, et al. Antiglucocorticoids, neurogenesis and depression. Mini Rev Med Chem. 2009;9:249–64.

    Article  CAS  PubMed  Google Scholar 

  64. Young AH. Antiglucocorticoid treatment for depression. Aust NZ J Psychiatry. 2006;40:402–5.

    Google Scholar 

  65. Krystallenia IA, Kaltsas GA, Isidori AM, Akker SA, Drake WM, Chew SL, et al. The prevalence and characteristic features of cyclicity and variability in Cushing’s disease. Eur J Endocrinol. 2009;160:1011–18.

    Article  Google Scholar 

  66. Boscaro M, Rampazzo A, Paoletta A, Scanarini M, Belluardo P, Fallo F, et al. Patterns of ACTH response to oCRH in Cushing’s disease: correlation with histological/immunocytochemical findings. Neuroendocrinology. 1994;60:237–42.

    Article  CAS  PubMed  Google Scholar 

  67. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358:55–68.

    Article  CAS  PubMed  Google Scholar 

  68. Carroll BJ, Cassidy F, Naftolowitz D, Tatham NE, Wilson WH, Iranmanesh A, et al. Pathophysiology of hypercortisolism in depression. Acta Psychiatr Scand Suppl. 2007;433:90–103.

    Article  CAS  PubMed  Google Scholar 

  69. Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F. Clinical correlates of major depression in Cushing’s disease. Psychopathology. 1998;31:302–6.

    Article  CAS  PubMed  Google Scholar 

  70. Sonino N, Fava GA. Serotonin, Cushing’s disease and depression. Psychother Psychosom. 1996;65:63–5.

    Article  CAS  PubMed  Google Scholar 

  71. Debono M, Ross RJ, Newel-Price J. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol. 2009;160:719–29.

    Article  CAS  PubMed  Google Scholar 

  72. Danilovicz K, Bruno OD, Manavela M, Gomez RM, Barkan A. Correction of cortisol overreplacement ameliorates morbidity in patients with hypopituitarism: a pilot study. Pituitary. 2008;11:279–85.

    Article  Google Scholar 

  73. Johannsson G, Stibrant Sunnerhagen K, Svensson J. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing’s disease. Clin Endocrinol. 2004;60:550–9.

    Article  CAS  Google Scholar 

  74. Romijn JA, Smit JWA, Lamberts SWJ. Intrinsic imperfections of endocrine replacement therapy. Eur J Endocrinol. 2003;149:91–7.

    Article  CAS  PubMed  Google Scholar 

  75. Sonino N. The need for rehabilitation teams in endocrinology. Expert Rev Endocrinol Metab. 2008;3:291–3.

    Article  Google Scholar 

  76. Sonino N, Fava GA. Rehabilitation in endocrine patients: a novel psychosomatic approach. Psychother Psychosom. 2007;76:319–24.

    Article  PubMed  Google Scholar 

  77. Fava GA, Sonino N. The biopsychosocial model thirty years later. Psychother Psychosom. 2008;77:1–2.

    Article  PubMed  Google Scholar 

  78. Sonino N, Peruzzi P. A psychoneuroendocrinology service. Psychother Psychosom. 2009;78:346–51.

    Article  PubMed  Google Scholar 

  79. Boscaro M, Arnaldi G. Approach to the patient with possible Cushing’s syndrome. J Clin Endocrinol Metab. 2009;94:3121–31.

    Article  CAS  PubMed  Google Scholar 

  80. Andrioli M, Pecori Giraldi F, De Martin M, Cattaneo A, Carzaniga C, Cavagnini F. Differential diagnosis of ACTH-dependent hypercortisolism: imaging versus laboratory. Pituitary 2009;12:294–6.

    Google Scholar 

  81. Kissane N, Cendan JC. Patients with Cushing’s syndrome are care-intensive even in the era of laparoscopic adrenalectomy. Am Surg. 2009;75:279–83.

    PubMed  Google Scholar 

  82. Hodish I, Giordano TJ, Starkman MN, Schteingart DE. Location of ectopic adrenocortical hormone-secreting tumors causing Cushing’s syndrome in the paranasal sinuses. Head Neck. 2009;31:699–706.

    Article  PubMed  Google Scholar 

  83. Jehle S, Walsh JE, Freda PU, Post KD. Selective use of bilateral inferior petrosal sinus sampling in patients with adrenocorticotropin-dependent Cushing’s syndrome prior to transsphenoidal surgery. J Clin Endocrinol Metab. 2008;93:4624–32.

    Article  CAS  PubMed  Google Scholar 

  84. Uz A, Biller BMK. The role of bilateral inferior petrosal sinus sampling in the diagnosis of Cushing’s syndrome. Arq Bras Endocrinol Metab. 2007;51:1329–38.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Statistical Sciences, University of Padova, Via Battisti 241, 35121, Padova, Italy

    Nicoletta Sonino

  2. Department of Mental Health, Padova, Italy

    Nicoletta Sonino

  3. Department of Psychiatry, State University of New York at Buffalo, Buffalo, NY, USA

    Nicoletta Sonino & Giovanni A. Fava

  4. Department of Medical and Surgical Science, University of Padova, Padova, Italy

    Francesco Fallo

  5. Department of Psychology, University of Bologna, Bologna, Italy

    Giovanni A. Fava

Authors
  1. Nicoletta Sonino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco Fallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giovanni A. Fava
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicoletta Sonino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sonino, N., Fallo, F. & Fava, G.A. Psychosomatic aspects of Cushing’s syndrome. Rev Endocr Metab Disord 11, 95–104 (2010). https://doi.org/10.1007/s11154-009-9123-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-009-9123-7

Keywords

Search

Navigation